Search for: "NATIONAL LEGISLATIVE ASSOCIATION ON PRESCRIPTION DRUG PRICES"
Results 1 - 20
of 105
Sorted by Relevance
|
Sort by Date
12 Oct 2022, 9:05 pm
Senators Bob Casey (D-Pa.) and Susan Collins (R-Maine) have introduced bipartisan legislation to increase drug price transparency. [read post]
16 Oct 2020, 9:07 pm
He asserts that an absence of a unified national approach to address drug prices has created a patchwork of state legislation. [read post]
26 Dec 2013, 4:00 pm
Officials are using the “National Precursor Log Exchange” to track who is buying prescription drugs and to indicate to pharmacies whether individuals have reached a limit. [read post]
17 Jun 2020, 6:30 am
Members of the claim management team and other interested stakeholders should take note of recent actions by the National Council of Insurance Legislators (NCOIL). [read post]
10 Oct 2016, 9:30 pm
Instead, private plans that administer Medicare’s prescription drug benefit individually negotiate with drug companies for lower prices. [read post]
28 Feb 2018, 4:38 pm
It further went to indicate that because the law is tied to a national measure of drug prices, advance notification requirement could restrict drugmakers’ ability to raise prices in other states. [read post]
9 May 2019, 8:06 am
While pharmaceutical drug manufactures generally must obtain approval from the FDA Office of Prescription Drug Promotion (ODPD) for advertising, OPDP does not review price information in prescription drug advertisements. [read post]
3 Jan 2012, 10:20 am
The short version is quite simple: drug and device companies really like activist judges legislating from the bench or overruling juries’ factual findings. [read post]
17 Nov 2021, 2:44 pm
The Departments say additional information on prescription drug rebates, fees, and other remunerations paid by drug manufacturers to plans, issuers, and pharmacy benefit managers—including the top 25 drugs generating the highest rebate amounts—will help the Departments understand and report on prescription drug costs, and how they fluctuate over time. [read post]
29 Nov 2023, 5:04 pm
Among its other provisions, the bill, for which final legislative text has not yet been released, would, for the first time, mandate minimum prices that Medicare Part D plans, and the pharmacy benefit managers (PBMs) with which they contract, must pay to certain types of pharmacies as reimbursement for the drugs they dispense to Part D plan enrollees. [read post]
13 Apr 2016, 7:40 am
TSCL is fighting high drug prices by working for legislation to allow Medicare to negotiate the price of prescription drugs. [read post]
25 Jan 2013, 5:42 am
But at least with regards to this issue, California leads the nation. [read post]
27 Dec 2013, 11:07 am
Officials are using the “National Precursor Log Exchange” to track who is buying prescription drugs and to indicate to pharmacies whether individuals have reached a limit. [read post]
13 Dec 2020, 7:09 pm
Pharmaceutical Care Management Association firmly rejected an attack on state statutes that protect pharmacies from the prescription-reimbursement intermediaries that health-insurance providers use to administer their prescription-drug programs. [read post]
18 Mar 2013, 4:00 am
Sharon Carson, R-Londonderry, that would give injured workers the right to choose where they get their prescription drugs. [read post]
16 Oct 2008, 9:14 pm
In addition, CMS will host a series of national provider calls regarding issues associated with the adoption of the ICD-10 coding system. [read post]
26 Jul 2012, 4:27 am
""If a prescription has been repackaged, the average wholesale price used to determine the maximum reimbursement shall be the average wholesale price for the underlying drug product, as identified by its National Drug Code from the original manufacturer," the rule states.The rule also provides that the "average wholesale price or its equivalent as registered by the National Drug Code shall be set… [read post]
30 Mar 2020, 2:42 pm
For instance, New York has five proposed bills that, taken together, target medical supplies price gouging and price gouging by manufacturers of prescription drugs, create a private right of action, define an unconscionably excessive price, and impose criminal penalties. [read post]
10 Dec 2019, 4:02 pm
This faster rate of growth was driven by non-price factors, such as the use and mix of drugs consumed, which more than offset a decline of 1.0 percent in prices for retail prescription drugs. [read post]
13 Jun 2019, 12:26 pm
Pursuant to European legislation, we have competent authorities, the European Medicines Agency (EMA) or national medicines evaluation board (MEB), seriously assessing the efficacy and safety of medicinal products before they enter the market. [read post]
